Patents Assigned to Xpecting Diagnostics, Inc.
  • Detection of analytes in bodily fluid to determine the initiation of parturition
    Patent number: 11079378
    Abstract: Devices and kits for detecting molecular targets involved in the onset of parturition are presented, as are methods of using the same. The devices and kits include one or more associators specific for molecular targets, such as microRNAs and proteins and peptide fragments thereof. The associators, such as aptamers or antibodies, bind their targets, when such targets are present in a fluid sample from a pregnant woman, to produce a detectable signal. The signal may be produced in a lateral flow device.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: August 3, 2021
    Assignee: Xpecting Diagnostics, Inc.
    Inventor: R. Tanner Hagelstrom